SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001346302-20-000007
Filing Date
2020-03-12
Accepted
2020-03-11 20:05:38
Documents
86
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2019form10-k.htm 10-K 2146426
2 EXHIBIT 4.3 a201910-kexhibit43.htm EX-4.3 48802
3 EXHIBIT 23.1 a201910-kexhibit231.htm EX-23.1 3666
4 EXHIBIT 31.1 a201910-kexhibit311.htm EX-31.1 14113
5 EXHIBIT 31.2 a201910-kexhibit312.htm EX-31.2 14190
6 EXHIBIT 32.1 a201910-kexhibit321.htm EX-32.1 7428
7 EXHIBIT 32.2 a201910-kexhibit322.htm EX-32.2 6929
14 feb2020pipelineslide228v3a01.jpg GRAPHIC 80993
15 figure1glucoselevelsv2a01.jpg GRAPHIC 31023
16 figure2glucoselevelsv2a01.jpg GRAPHIC 30428
17 gvokemarketinggraph3.jpg GRAPHIC 143421
18 minidoseclinicalresultsa01.jpg GRAPHIC 28958
19 rangeofhypoglycemiaa01.jpg GRAPHIC 26110
  Complete submission text file 0001346302-20-000007.txt   7832778

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT xers-20191231.xml EX-101.INS 1222484
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20191231.xsd EX-101.SCH 51425
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20191231_cal.xml EX-101.CAL 42140
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20191231_def.xml EX-101.DEF 266050
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20191231_lab.xml EX-101.LAB 649893
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20191231_pre.xml EX-101.PRE 397378
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38536 | Film No.: 20706925
SIC: 2834 Pharmaceutical Preparations